Infex Therapeutics announces positive Phase IIa results for RESP-X in non-cystic fibrosis bronchiectasis patients colonised with Pseudomonas aeruginosa
Study met its primary objective demonstrating excellent safety and tolerability, of RESP-X…
Regional Health Properties Reports First Quarter 2026 Results
Reported First Quarter Revenue of $21.2 millionGenerated Adjusted EBITDA from Operations of…
Allarity Therapeutics Reports First Quarter 2026 Results and Continued Stenoparib Development in Multiple Cancers
- Stenoparib clinical development continues in relapsed small cell lung cancer and,…
Range Impact Reports 1Q 2026 Financial Results
CLEVELAND, OHIO, May 15, 2026 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC:…
Constellation Software Inc. Announces Results of Voting for Directors at Annual General Shareholders Meeting
May 15, 2026 20:23 ET | Source: Constellation Software Inc. TORONTO, May…
Oncotelic Therapeutics Files First Quarter 2026 Financial Results and Strategic Progress
Agoura Hills, Calif., May 15, 2026 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc.…
Vaso Corporation Announces Financial Results for First Quarter of 2026
May 15, 2026 09:00 ET | Source: Vaso Corporation PLAINVIEW, N.Y., May…
Cypherpunk Technologies Reports First Quarter 2026 Financial Results
CAMBRIDGE, Mass., May 14, 2026 /PRNewswire/ -- Cypherpunk Technologies Inc., (Nasdaq: CYPH)…
Aptose Reports First Quarter 2026 Results
SAN DIEGO and TORONTO, May 13, 2026 (GLOBE NEWSWIRE) -- Aptose Biosciences…
ZyVersa Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
ZyVersa is advancing a highly differentiated pipeline focusing on inflammatory and renal…
